Clinical Trials in North Melbourne, Victoria
4 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 2Phase 3
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
Bicara Therapeutics650 enrolled129 locationsNCT06788990
Recruiting
Not Applicable
Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction
Erectile Dysfunction Following Radical Prostatectomy
Comphya Australia20 enrolled4 locationsNCT05650866
Recruiting
Phase 1
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
Triple-Negative Breast CancerColorectal, CancerPancreatic Cancer+6 more
Monopar Therapeutics12 enrolled1 locationNCT06337084
Recruiting
Phase 1
Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors
Triple-Negative Breast CancerColorectal, CancerPancreatic Cancer+6 more
Monopar Therapeutics12 enrolled1 locationNCT06617169